Loading...
XNASINCR
Market cap77mUSD
Dec 26, Last price  
1.68USD
1D
-1.18%
1Q
-11.58%
IPO
-33.07%
Name

InterCure Ltd

Chart & Performance

D1W1MN
XNAS:INCR chart
P/E
—
P/S
0.79
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
17.21%
Rev. gr., 5y
398.05%
Revenues
356m
-8.52%
13,226,90612,068,8268,469,3758,250,0425,650,0921,401,4130008,926,00065,035,000219,677,000388,684,000355,553,000
Net income
-62m
L
0-6,801,32243,441,510000265,4150-12,798,000-2,996,000-36,040,0007,296,00044,819,000-61,959,000
CFO
-54m
L
0-860,15600000-921,034-1,486,000-4,013,0007,803,00025,020,00051,267,000-53,631,000

Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
URL
https://www.intercure.co/
IPO date
Jul 26, 2007
Employees
370
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
355,553
-8.52%
388,684
76.93%
219,677
237.78%
Cost of revenue
337,083
331,551
183,720
Unusual Expense (Income)
NOPBT
18,470
57,133
35,957
NOPBT Margin
5.19%
14.70%
16.37%
Operating Taxes
2,248
93
11,441
Tax Rate
12.17%
0.16%
31.82%
NOPAT
16,222
57,040
24,516
Net income
(61,959)
-238.24%
44,819
514.30%
7,296
-120.24%
Dividends
Dividend yield
Proceeds from repurchase of equity
128,730
BB yield
-13.24%
Debt
Debt current
92,834
132,374
75,588
Long-term debt
128,124
150,237
58,002
Deferred revenue
Other long-term liabilities
841
1,025
223
Net debt
117,710
7,252
(65,522)
Cash flow
Cash from operating activities
(53,631)
51,267
25,020
CAPEX
(2,619)
(19,742)
(14,029)
Cash from investing activities
4,773
(142,497)
(65,210)
Cash from financing activities
(82,889)
120,446
203,057
FCF
(69,030)
(32,321)
(19,079)
Balance
Cash
101,326
232,794
196,547
Long term investments
1,922
42,565
2,565
Excess cash
85,470
255,925
188,128
Stockholders' equity
457,062
512,936
450,650
Invested Capital
568,110
521,737
380,201
ROIC
2.98%
12.65%
7.65%
ROCE
2.83%
7.35%
6.33%
EV
Common stock shares outstanding
45,573
45,353
46,920
Price
4.63
-61.66%
12.08
-41.70%
20.72
26.72%
Market cap
211,047
-61.48%
547,859
-43.65%
972,182
134.12%
EV
330,707
575,283
917,823
EBITDA
31,636
68,832
43,350
EV/EBITDA
10.45
8.36
21.17
Interest
24,219
14,689
5,045
Interest/NOPBT
131.13%
25.71%
14.03%